Quantcast

Bladder Cancer Advocacy Network (BCAN) Sponsors New York Forum to Educate Patients and Families About Bladder Cancer

October 19, 2010

Fifth Most Frequently Diagnosed Cancer in U.S. Affects Approximately 70,000 Americans Each Year

NEW YORK, Oct. 19 /PRNewswire-USNewswire/ – Bladder cancer is the fifth most commonly diagnosed cancer in the United States, yet most people know nothing about it. To help enhance the public’s understanding of the risks and signs of bladder cancer and the importance of early detection and treatment options, the Bladder Cancer Advocacy Network (BCAN) will hold its regional Bladder Cancer Patient Forum “Understanding Bladder Cancer” on Saturday, October 23, 2010, in New York City at the New York Academy of Medicine. The forum is expected to unite, support, and inspire more than 200 bladder cancer patients, their loved ones, and caregivers.

“Many people don’t realize how prevalent bladder cancer is, and are unaware of the signs and symptoms of the disease. As a result, patients that suffer from bladder cancer often feel isolated,” said Diane Zipursky Quale, president and co-founder of BCAN. “Our goal of hosting the forum is to give people affected by bladder cancer a better understanding of this life-changing disease and the resources available to help them.”

Panel of Bladder Cancer Specialists and Topics

Dr. Bernard Bochner of Memorial Sloan-Kettering Cancer Center (MSKCC) and Dr. James McKiernan of Columbia University Medical Center (CUMC) will lead a panel of bladder cancer specialists to provide a complete overview of the disease, treatment, and recent advances. Below is a brief overview of the forum’s panel members and the topics that will be discussed.

  • James McKiernan, MD, CUMC: Bladder Cancer Basics
  • William Huang, MD, New York University Medical Center: Detection and Diagnosis
  • Simon Hall, MD, Mount Sinai School of Medicine: Treatment and Surveillance of Non-Muscle Invasive Bladder Cancer
  • Bernard Bochner, MD, MSKCC: Surgery and Urinary Reconstruction for Muscle-Invasive Bladder Cancer
  • Douglas Scherr, MD, Weill Cornell Medical College: Innovations in the Treatment of Bladder Cancer;
  • Daniel Petrylak, MD, CUMC: Chemotherapy for Muscle-Invasive Bladder Cancer.

Attendees will also take part in an interactive discussion on “Living with Bladder Cancer.”

About Bladder Cancer

Approximately 70,000 new cases of bladder cancer are diagnosed annually in the United States, and more than 14,000 Americans die from the disease each year. Smokers are at high risk of bladder cancer. The chance of getting bladder cancer increases as people age. Men are two to three times more likely than women to be diagnosed with bladder cancer, yet women are more likely to be diagnosed at a later stage. The most frequent symptom of the disease is blood in the urine – a signal that one should see one’s doctor immediately.( )

About the Bladder Cancer Advocacy Network

The Bladder Cancer Advocacy Network (BCAN – pronounced beacon) is the first national advocacy organization dedicated to improving public awareness of bladder cancer, advancing bladder cancer research and providing information and support to people affected by bladder cancer. Founded in May 2005, BCAN is a cooperative effort among bladder cancer survivors, their loved ones and the medical community.

To attend this patient forum, or for more information about bladder cancer, please visit www.bcan.org or call 888-901-BCAN. Preregistration is required because space is limited and lunch is provided. Registration is $20 per person.

SOURCE Bladder Cancer Advocacy Network


Source: newswire



comments powered by Disqus